Current strategies to generate mature human induced pluripotent stem cells derived cholangiocytes and future applications

Eduardo Cervantes-Alvarez, Yang Wang, Alexandra Collin de l'Hortet, Jorge Guzman-Lepe, Jiye Zhu, kazuki takeishi

研究成果: ジャーナルへの寄稿評論記事

3 引用 (Scopus)

抄録

Stem cell research has significantly evolved over the last few years, allowing the differentiation of pluripotent cells into almost any kind of lineage possible. Studies that focus on the liver have considerably taken a leap into this novel technology, and hepatocyte-like cells are being generated that are close to resembling actual hepatocytes both genotypically and phenotypically. The potential of this extends from disease models to bioengineering, and even also innovative therapies for end-stage liver disease. Nonetheless, too few attention has been given to the non-parenchymal cells which are also fundamental for normal liver function. This includes cholangiocytes, the cells of the biliary epithelium, without whose role in bile modification and metabolism would impair hepatocyte survival. Such can be observed in diseases that target them, so called cholangiopathies, for which there is much yet to study so as to improve therapeutical options. Protocols that describe the induction of human induced pluripotent stem cells into cholangiocytes are scarce, although progress is being achieved in this area as well. In order to give the current view on this emerging research field, and in hopes to motivate further advances, we present here a review on the known differentiation strategies with sight into future applications.

元の言語英語
ページ(範囲)1-15
ページ数15
ジャーナルOrganogenesis
13
発行部数1
DOI
出版物ステータス出版済み - 1 2 2017
外部発表Yes

Fingerprint

Induced Pluripotent Stem Cells
Stem cells
Liver
Hepatocytes
Stem Cell Research
Bioengineering
Investigational Therapies
End Stage Liver Disease
Metabolism
Bile
Cell Differentiation
Epithelium
Cells
Technology
Research

All Science Journal Classification (ASJC) codes

  • Embryology
  • Biomedical Engineering
  • Developmental Biology
  • Transplantation

これを引用

Current strategies to generate mature human induced pluripotent stem cells derived cholangiocytes and future applications. / Cervantes-Alvarez, Eduardo; Wang, Yang; Collin de l'Hortet, Alexandra; Guzman-Lepe, Jorge; Zhu, Jiye; takeishi, kazuki.

:: Organogenesis, 巻 13, 番号 1, 02.01.2017, p. 1-15.

研究成果: ジャーナルへの寄稿評論記事

Cervantes-Alvarez, Eduardo ; Wang, Yang ; Collin de l'Hortet, Alexandra ; Guzman-Lepe, Jorge ; Zhu, Jiye ; takeishi, kazuki. / Current strategies to generate mature human induced pluripotent stem cells derived cholangiocytes and future applications. :: Organogenesis. 2017 ; 巻 13, 番号 1. pp. 1-15.
@article{6e2f841099944ec29d9535edb7b028a9,
title = "Current strategies to generate mature human induced pluripotent stem cells derived cholangiocytes and future applications",
abstract = "Stem cell research has significantly evolved over the last few years, allowing the differentiation of pluripotent cells into almost any kind of lineage possible. Studies that focus on the liver have considerably taken a leap into this novel technology, and hepatocyte-like cells are being generated that are close to resembling actual hepatocytes both genotypically and phenotypically. The potential of this extends from disease models to bioengineering, and even also innovative therapies for end-stage liver disease. Nonetheless, too few attention has been given to the non-parenchymal cells which are also fundamental for normal liver function. This includes cholangiocytes, the cells of the biliary epithelium, without whose role in bile modification and metabolism would impair hepatocyte survival. Such can be observed in diseases that target them, so called cholangiopathies, for which there is much yet to study so as to improve therapeutical options. Protocols that describe the induction of human induced pluripotent stem cells into cholangiocytes are scarce, although progress is being achieved in this area as well. In order to give the current view on this emerging research field, and in hopes to motivate further advances, we present here a review on the known differentiation strategies with sight into future applications.",
author = "Eduardo Cervantes-Alvarez and Yang Wang and {Collin de l'Hortet}, Alexandra and Jorge Guzman-Lepe and Jiye Zhu and kazuki takeishi",
year = "2017",
month = "1",
day = "2",
doi = "10.1080/15476278.2016.1278133",
language = "English",
volume = "13",
pages = "1--15",
journal = "Organogenesis",
issn = "1547-6278",
publisher = "Landes Bioscience",
number = "1",

}

TY - JOUR

T1 - Current strategies to generate mature human induced pluripotent stem cells derived cholangiocytes and future applications

AU - Cervantes-Alvarez, Eduardo

AU - Wang, Yang

AU - Collin de l'Hortet, Alexandra

AU - Guzman-Lepe, Jorge

AU - Zhu, Jiye

AU - takeishi, kazuki

PY - 2017/1/2

Y1 - 2017/1/2

N2 - Stem cell research has significantly evolved over the last few years, allowing the differentiation of pluripotent cells into almost any kind of lineage possible. Studies that focus on the liver have considerably taken a leap into this novel technology, and hepatocyte-like cells are being generated that are close to resembling actual hepatocytes both genotypically and phenotypically. The potential of this extends from disease models to bioengineering, and even also innovative therapies for end-stage liver disease. Nonetheless, too few attention has been given to the non-parenchymal cells which are also fundamental for normal liver function. This includes cholangiocytes, the cells of the biliary epithelium, without whose role in bile modification and metabolism would impair hepatocyte survival. Such can be observed in diseases that target them, so called cholangiopathies, for which there is much yet to study so as to improve therapeutical options. Protocols that describe the induction of human induced pluripotent stem cells into cholangiocytes are scarce, although progress is being achieved in this area as well. In order to give the current view on this emerging research field, and in hopes to motivate further advances, we present here a review on the known differentiation strategies with sight into future applications.

AB - Stem cell research has significantly evolved over the last few years, allowing the differentiation of pluripotent cells into almost any kind of lineage possible. Studies that focus on the liver have considerably taken a leap into this novel technology, and hepatocyte-like cells are being generated that are close to resembling actual hepatocytes both genotypically and phenotypically. The potential of this extends from disease models to bioengineering, and even also innovative therapies for end-stage liver disease. Nonetheless, too few attention has been given to the non-parenchymal cells which are also fundamental for normal liver function. This includes cholangiocytes, the cells of the biliary epithelium, without whose role in bile modification and metabolism would impair hepatocyte survival. Such can be observed in diseases that target them, so called cholangiopathies, for which there is much yet to study so as to improve therapeutical options. Protocols that describe the induction of human induced pluripotent stem cells into cholangiocytes are scarce, although progress is being achieved in this area as well. In order to give the current view on this emerging research field, and in hopes to motivate further advances, we present here a review on the known differentiation strategies with sight into future applications.

UR - http://www.scopus.com/inward/record.url?scp=85010703118&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85010703118&partnerID=8YFLogxK

U2 - 10.1080/15476278.2016.1278133

DO - 10.1080/15476278.2016.1278133

M3 - Review article

C2 - 28055309

AN - SCOPUS:85010703118

VL - 13

SP - 1

EP - 15

JO - Organogenesis

JF - Organogenesis

SN - 1547-6278

IS - 1

ER -